Recruiting NA INTERVENTIONAL 1-arm NCT06626269

Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies (HORIZON)

Sponsor: Centre Hospitalier Universitaire de Besancon

Conditions Advanced Digestive Cancer Advanced Gynecologic Cancer

Updated 4 times since 2024 Last updated: Jun 17, 2025 Started: Feb 10, 2025 Primary completion: Feb 28, 2030 Completion: Feb 29, 2032

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Advanced Digestive Cancer and Advanced Gynecologic Cancer, this trial is actively recruiting participants. The trial is conducted by Centre Hospitalier Universitaire de Besancon and has accumulated 4 data snapshots since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Recruiting NA
Jul 2025 — Sep 2025 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2025 — Jul 2025 [monthly]

Not Yet Recruiting NA
Nov 2024 — Jan 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Besancon

Data source: Centre Hospitalier Universitaire de Besancon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Besançon, France
• Dijon, France